United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Report 2021

August 2016 | 121 pages | ID: U14E39ADD57EN
QYResearch

Abstracts

This report studies sales (consumption) of 23-Valent Pneumococcal Polysaccharide Vaccine in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering

• MSD
• Sanofipasteur
• CDIBP

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Single Dose Vial
• Pre-filled Syringe

Split by applications, this report focuses on sales, market share and growth rate of 23-Valent Pneumococcal Polysaccharide Vaccine in each application, can be divided into

• For Children (2-10)
• For Person (10-64)
• For The old (≥65)

Contents

United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Report 2021

1 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE OVERVIEW

1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
  1.2.1 Single Dose Vial
  1.2.2 Pre-filled Syringe
1.3 Applications of 23-Valent Pneumococcal Polysaccharide Vaccine
  1.3.1 For Children (2-10)
  1.3.2 For Person (10-64)
  1.3.3 For The old (≥65)
1.4 USA Market Size (Value and Volume) of 23-Valent Pneumococcal Polysaccharide Vaccine (2011-2021)
  1.4.1 USA 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Price (2011-2021)
  1.4.2 USA 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2011-2021)
  1.4.3 USA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2011-2021)

2 USA 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE COMPETITION BY MANUFACTURERS

2.1 USA 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Share by Manufactures (2015 and 2016)

3 USA 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (VOLUME AND VALUE) BY TYPE

3.1 USA 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2011-2021)
3.2 USA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2011-2021)

4 USA 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (VOLUME) BY APPLICATION

5 USA 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MANUFACTURERS ANALYSIS

5.1 MSD
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type and Technology
    5.1.2.1 Single Dose Vial
    5.1.2.2 Pre-filled Syringe
  5.1.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price of MSD (2015 and 2016)
5.2 Sanofipasteur
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 Single Dose Vial
    5.2.2.2 Pre-filled Syringe
  5.2.3 Pharmaceuticals Sales, Revenue, Price of Sanofipasteur (2015 and 2016)
5.3 CDIBP
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 CDIBP Product Type and Technology
    5.3.2.1 Single Dose Vial
    5.3.2.2 Pre-filled Syringe
  5.3.3 CDIBP Sales, Revenue, Price of CDIBP (2015 and 2016)

6 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE TECHNOLOGY AND DEVELOPMENT TREND

6.1 23-Valent Pneumococcal Polysaccharide Vaccine Technology Analysis
6.2 23-Valent Pneumococcal Polysaccharide Vaccine Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure USA Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2015
Figure Single Dose Vial Picture
Figure Pre-filled Syringe Picture
Table Applications of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure USA Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2015
Figure For Children (2-10) Examples
Figure For Person (10-64) Examples
Figure For The old (≥65) Examples
Table USA 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Price (2011-2021)
Figure USA 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2011-2021)
Figure USA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2011-2021)
Table USA AAA Sales of Key Manufacturers (2015 and 2016)
Table USA AAA Sales Share by Manufacturers (2015 and 2016)
Figure 2015 AAA Sales Share by Manufacturers
Figure 2016 AAA Sales Share by Manufacturers
Table USA AAA Revenue by Manufacturers (2015 and 2016)
Table USA AAA Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA AAA Revenue Share by Manufacturers
Table 2016 USA AAA Revenue Share by Manufacturers
Table USA AAA Sales and Market Share by Type (2011-2021)
Table USA AAA Sales Share by Type (2011-2021)
Figure Sales Market Share of AAA by Type (2011-2021)
Figure USA AAA Sales Growth Rate by Type (2011-2021)
Table USA AAA Revenue and Market Share by Type (2011-2021)
Table USA AAA Revenue Share by Type (2011-2021)
Figure Revenue Market Share of AAA by Type (2011-2021)
Figure USA AAA Revenue Growth Rate by Type (2011-2021)
Table USA AAA Sales and Market Share by Application (2011-2021)
Table USA AAA Sales Share by Application (2011-2021)
Figure Sales Market Share of AAA by Application (2011-2021)
Figure USA AAA Sales Growth Rate by Application (2011-2021)
Table MSD Basic Information List
Table 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price of MSD (2015 and 2016)
Table Sanofipasteur Basic Information List
Table 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price of Sanofipasteur (2015 and 2016)
Table CDIBP Basic Information List
Table 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price of CDIBP (2015 and 2016 )